Pharmacokinetics Study of TNO155 in Participants With Mild, Moderate, or Severe Renal Impairment Compared to Matched Healthy Participants

Clinical trial NCT05541159 · WITHDRAWN

Trial details

NCT number: NCT05541159
Sponsor: Novartis Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Impairment

Start date: 2025-03-19
Primary completion: 2025-07-15
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.